(a) The structure of Arbidol. (b) KYSE150, KYSE450, and shantou human embryonic esophageal (SHEE) cell viability was detected by the IN Cell Analyzer. KYSE150 and KYSE450 cells were treated with …
(a) The mass spectrometry workflow of phosphorylated proteomics analysis of KYSE150 cells after 24 hr treatment with Arbidol. (b) Histogram shows the regulation of phosphorylation sites compared to …
The original data of western blot in Figure 2.
The KYSE150 cell lysate (500 μg) was incubated with sepharose 4B beads conjugated with Arbidol or sepharose 4B beads alone. Western blot analysis was used to analyze the pull-down protein.
Arbidol did not bind directly to CDC7.
(a) Computational docking was used to identify the binding site of Arbidol and ATR. (b-d) Arbidol directly binds to ATR. The ATR pure protein (1 μg) (b) and esophageal squamous cell carcinoma (ESCC) …
The original data of western blot in Figure 3.
(a) Coomassie blue-stained gel of purified minichromosome maintenance 2 (MCM2), the black arrow indicates MCM2. (b) Mutant ataxia telangiectasia and Rad3-related (ATR) protein purified by coomassie …
(a) Gene Set Enrichment Analysis (GSEA) indicates the representation of the cell cycle pathway in both the phosphoproteomics and proteomics datasets. (b) The expression level of p-minichromosome …
The original data of western blot in Figure 4.
(a, b) Gene set enrichment analysis (GSEA) included the phosphoproteomics (a) and proteomics (b) datasets. The black arrow indicates minichromosome maintenance 2 (MCM2) and ataxia telangiectasia and …
(a, b, c) Arbidol did not bind directly to CDK2, CDK4, CDK6. Recombinant CDK2 protein (a) recombinant CDK4 protein (b) recombinant CDK6 protein (c) (500 μg) were incubated with sepharose 4B beads …
The original data of western Blot in Figure 4—figure supplement 2.
(a) The correlation between ataxia telangiectasia and Rad3-related (ATR) and minichromosome maintenance 2 (MCM2) was detected by gene correlation analysis. (b) The Cancer Genome Atlas data results …
The original data of western blot in Figure 5.